Taverna et al. demonstrated that Amphiregulin, a ligand of EGFR contained in NSCLC-EVs, could induce metastasis, activating the EGFR pathway in pre-osteoclasts with an enhanced activity of proteolytic enzymes, leading to bone metastasis formation [120]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.